141 related articles for article (PubMed ID: 32493543)
1. Prominent Enhancement of Cisplatin Efficacy with Optimized Methoxy Poly(ethylene glycol)-Polycaprolactone Block Copolymeric Nanoparticles.
Yen YT; Wang X; Zhang H; Wang C; Lin Z; Xie C; Liu Q; Wang L; Yu L; Li X; Lv X; Liu B; Li R
J Biomed Nanotechnol; 2020 Mar; 16(3):335-343. PubMed ID: 32493543
[TBL] [Abstract][Full Text] [Related]
2. Biocompatible Nanoparticles as a Platform for Enhancing Antitumor Efficacy of Cisplatin-Tetradrine Combination.
Liu F; Wang X; Liu Q; Zhang H; Xie L; Wang Q; Li L; Li R
Nanoscale Res Lett; 2021 Apr; 16(1):61. PubMed ID: 33855646
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
4. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
5. Facile Optimization and Evaluation of PEG-PCL Block Copolymeric Nanoparticles for Anticancer Drug Delivery Using Copolymer Hybrids and Histoculture Drug Response Assays.
Li R; Yan J; Xie L; Zhang Y; Gao J; Liu Q; Lin Z; Jiang P; Qian H; Yang M; Wu F; Jiang X; Liu B; Wang L
J Biomed Nanotechnol; 2018 Feb; 14(2):321-330. PubMed ID: 31352928
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
Kates M; Date A; Yoshida T; Afzal U; Kanvinde P; Babu T; Sopko NA; Matsui H; Hahn NM; McConkey DJ; Baras A; Hanes J; Ensign L; Bivalacqua TJ
Clin Cancer Res; 2017 Nov; 23(21):6592-6601. PubMed ID: 28808039
[No Abstract] [Full Text] [Related]
8. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
10. Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Int J Pharm; 2020 Jan; 573():118729. PubMed ID: 31705975
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.
Shi C; Yu H; Sun D; Ma L; Tang Z; Xiao Q; Chen X
Acta Biomater; 2015 May; 18():68-76. PubMed ID: 25707922
[TBL] [Abstract][Full Text] [Related]
12. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin loaded methoxy poly (ethylene glycol)-block-Poly (L-glutamic acid-co-L-Phenylalanine) nanoparticles against human breast cancer cell.
Ahmad Z; Tang Z; Shah A; Lv S; Zhang D; Zhang Y; Chen X
Macromol Biosci; 2014 Sep; 14(9):1337-45. PubMed ID: 24933015
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
[TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinase-Responsive Multifunctional Peptide-Linked Amphiphilic Block Copolymers for Intelligent Systemic Anticancer Drug Delivery.
Ke W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
Bioconjug Chem; 2017 Aug; 28(8):2190-2198. PubMed ID: 28661654
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma.
Li Q; Liu X; Yan W; Chen Y
Aging (Albany NY); 2020 Dec; 13(2):2593-2603. PubMed ID: 33323546
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
18. [Preparation, characterization and Calu-3 cellular uptake of three kinds of poly(b-benzyl-L-amino)block-poly(ethylene glycol) nanoparticles].
Zhou Y; Lu LN; Xin X; Huo DF; Wu HB; Qiu MF
Yao Xue Xue Bao; 2013 Apr; 48(4):560-5. PubMed ID: 23833946
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice.
Wang Y; Liu P; Qiu L; Sun Y; Zhu M; Gu L; Di W; Duan Y
Biomaterials; 2013 May; 34(16):4068-4077. PubMed ID: 23480957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
